(Q51147930)

31 March 2018

title

Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. (English)

1 reference

31 March 2018

1 reference

Yang Liu

1

1 reference

31 March 2018

Fan Li

2

1 reference

31 March 2018

Feng Gao

3

1 reference

31 March 2018

Lingxi Xing

4

1 reference

31 March 2018

Peng Qin

5

1 reference

31 March 2018

Xingxin Liang

6

1 reference

31 March 2018

Jiajie Zhang

7

1 reference

31 March 2018

Xiaohui Qiao

8

1 reference

31 March 2018

Lizhou Lin

9

1 reference

31 March 2018

Qian Zhao

10

1 reference

31 March 2018

Lianfang Du

11

1 reference

31 March 2018

publication date

30 September 2016

1 reference

31 March 2018

published in

Tumor Biology

1 reference

31 March 2018

volume

37

1 reference

31 March 2018

issue

11

1 reference

31 March 2018

page(s)

15283-15291

1 reference

31 March 2018

https://scigraph.springernature.com/pub.10.1007/s13277-016-5321-6

exact match

0 references

cites work

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

The role of stroma in pancreatic cancer: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Stromal reengineering to treat pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Pancreatic stellate cells: partners in crime with pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Role of pancreatic stellate cells and periostin in pancreatic cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Key role of pancreatic stellate cells in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Gemcitabine resistance in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Mitochondrial aldehyde dehydrogenase 2 protects gastric mucosa cells against DNA damage caused by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5321-6

Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27696296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27696296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27696296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-016-5321-6

1 reference

31 March 2018

1 reference

31 March 2018